Rosiglitazone Decreases Plasma Levels of Osteoprotegerin in a Randomized Clinical Trial with Type 2 Diabetes Patients

✍ Scribed by Mads Nybo; Simone Rørdam Preil; Henning Friis Juhl; Malene Olesen; Knud Yderstræde; Jeppe Gram; Jan Erik Henriksen; Lars Melholt Rasmussen

• Book ID: 111316992
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 146 KB
• Volume: 109
• Category: Article
• ISSN: 1742-7835
• DOI: 10.1111/j.1742-7843.2011.00752.x